VIH y COVID-19: Una revisión narrativa rápida.
Resumen
Introducción: El impacto del SARS-CoV-2 en la pandemia del VIH, era desconocido en enero del 2020, pero transcurridos casi seis meses de la aparición del COVID-19, ya contamos con variadas publicaciones académicas de esta sindemia.
El presente artículo es una revisión narrativa rápida de la literatura científica actual sobre VIH y COVID-19.
Metodología: Se revisaron publicaciones en buscadores académicos a mediados de mayo del 2020 sobre VIH y COVID-19.
Se encontraron editoriales y cartas al editor, correspondencia, viewpoint, artículos originales [algunos pre-print], notas de campo y comentarios. Todos con valiosa información clínica sobre la relación entre ambas epidemias.
Desarrollo: Se clasificaron las publicaciones temáticamente en: respuesta clínica de personas VIH positivas afectadas por el COVID-19, farmacología, mantención y adaptación de los servicios de salud sexual, lecciones del VIH para la respuesta al COVID-19, poblaciones clave, efectos psicosociales, estigma y discriminación.
Conclusiones: No hay evidencia de que personas VIH positivas, en TARV y por tanto, sin compromiso inmune, tengan mayor riesgo de COVID-19; tampoco en personas en etapa SIDA.
Sí hay evidencia de mayor riesgo con edad avanzada y comorbilidades. No hay evidencia que sostenga que el TARV es efectivo para el SARS-CoV-2.
Los servicios de salud sexual pueden y deben adaptarse a la contingencia. El VIH entrega importantes lecciones para la respuesta al COVID-19. Las poblaciones clave, requieren especial protección.
Los efectos psicosociales y el estigma y la discriminación del COVID-19 y el VIH, generan impactos en la respuesta de la epidemia.
Citas
1. Kenmoe S, Bigna J, Fatawou Modiyingi A, Ndangang M, Ngoupo P, Simo F et al. Case fatality rate and viral aetiologies of acute respiratory tract infections in HIV positive and negative people in Africa: The VARIAFRICAHIV systematic review and metaanalysis. Journal of Clinical Virology. 2019; 117: 96-102. https://doi.org/10.1016/j.jcv.2019.06.006
2. Villamil-Gómez W, Sánchez Á, Gelis L, Silvera L, Barbosa J, Otero-Nader O et al. Fatal human coronavirus 229E (HCoV-229E) and RSV–Related pneumonia in an AIDS patient from Colombia. Travel Medicine and Infectious Disease. 2020; https://doi.org/10.1016/j.tmaid.2020.101573
3. Center for Disease Control [CDC]. What to know about HIV and COVID19. 2020 [cited 14 June 2020]. Available from:
https://www.cdc.gov/coronavirus/2019-ncov/need-extraprecautions/hiv.html
4. Yang R, Gui X, Gao S, et al. The reflection on an AIDS patient with asymptomatic COVID-19. Research Square [preprint]. 2020.
DOI: 10.21203/rs.3.rs-18738/v1
5. Favas, C. Guidance for the prevention of COVID-19 infections among high risk individuals in camps and camp like settings. London School of Hygiene & Tropical Medicine. 31 March 2020 [cited 11 June 2020]. Available from:
https://www.alnap.org/helplibrary/guidance-for-the-preventionof-covid-19-infection-among-highrisk-individuals-in-camps
6. Moni M, Liò P. Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies. BMC Bioinformatics.
2014;15(1):1-23. https://doi.org/10.1186/1471-2105-15-333
7. Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clinical Infectious Diseases [preprint]. 2020 [cited 7 June 2020]. Available from: https://pubmed.ncbi.nlm.nih.gov/3240 7467/
8. Härter, G., Spinner, C.D., Roider, J. et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection (2020). https://doi.org/10.1007/s15010-020-01438-z
9. Wu Q, Chen T, Zhang H. Recovery from COVID-19 in two patients with coexisted HIV infection. J Med Virol [preprint]. 2020 [cited 7 June 2020]. Recuperado de: https://doi.org/10.1002/jmv.26006
10. Blanco J, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J et al. COVID-19 in patients with HIV: clinical case series. The Lancet HIV. 2020;7(5): e314-e316. https://doi.org/10.1016/S2352-3018(20)30111-9
11. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey. Journal of Medical Virology [Internet]. 2020 [cited 8 June 2020];1-3. https://doi.org/10.1002/jmv.25955
12. Laurence J. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?. AIDS
Patient Care and STDs. 2020;34(6):247-248. https://doi.org/10.1089/apc.2020.29005.com
13. Zhao J, Liao X, Wang H, et al. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV [published online ahead of print, 2020 Apr 9]. Clin Infect Dis.2020; ciaa408. https://doi.org/10.1093/cid/ciaa408
14. Guo, Wei and Ming, Fangzhao and Dong, Yu and Zhang, Qian and Zhang, Xiaoxia and Mo, Pingzheng and Feng, Yong and Liang, Ke. A Survey for COVID-19 Among HIV/AIDS Patients in Two Districts of Wuhan, China. The Lancet [preprint]. Available at
http://dx.doi.org/10.2139/ssrn.3550029
15. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine. 2020;382(19):1787-1799. DOI: 10.1056/NEJMoa2001282
16. Copertino Jr. D, Lima B, Duarte R, Wilkin T, Gulick R, de Mulder Rougvie M et al. Antiretroviral Drug Activity and Potential for PreExposure Prophylaxis Against COVID-19 and HIV Infection. ChemRxiv [preprint]. 2020 [cited 8 June 2020]. Available from:
https://chemrxiv.org/articles/Antiretro viral_Drug_Activity_and_Potential_for_PreExposure_Prophylaxis_Against_COVID19_and_HIV_Infection/12250199/1?file=22537484
17. Mitjà O, Clotet B. Use of antiviral drugs to reduce COVID-19 transmission. The Lancet Global Health. 2020;8(5): e639-e640.
https://doi.org/10.1016/S2214-109X(20)30114-5
18. Lack of evidence to support use of darunavir-based treatments for SARSCoV-2 [Internet]. Janssen UK. 2020 [cited 15 June 2020]. Available from: https://www.janssen.com/uk/sars-cov2-treatment
19. Nyoni, T., Okumu, M. COVID-19- Compliant Strategies for Supporting Treatment Adherence Among People Living with HIV in Sub-Saharan Africa. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02888-0
20. Lodge W, Kuchukhidze S. COVID-19, HIV, and Migrant Workers: The Double Burden of the Two Viruses. AIDS Patient Care and STDs.
2020;34(6):249-250. DOI: https://doi.org/10.1089/apc.2020.0092
21. Shiau, S., Krause, K.D., Valera, P. et al. The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-02871-9
22. Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. The Lancet HIV. 2020;7(5): e308-e309.
https://doi.org/10.1016/S2352-3018(20)30105-3
23. Stanford, K.A., Friedman, E.E., Schmitt, J. et al. Routine Screening for HIV in an Urban Emergency Department During the COVID-19
Pandemic. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02899-x
24. Nosyk B, Armstrong W, del Rio C. Contact tracing for COVID-19: An opportunity to reduce health disparities and End the HIV/AIDS Epidemic in the US. Clinical Infectious Diseases [preprint]. 2020 [cited 7 June 2020]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197593/
25. Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. The Lancet HIV. 2020;7(5): e319-e320. https://doi.org/10.1016/S2352-3018(20)30109-0
26. Beima-Sofie, K., Ortblad, K.F., Swanson, F. et al. “Keep It Going if You Can”: HIV Service Provision for Priority Populations During the
COVID-19 Pandemic in Seattle, WA. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-0290
27. McLinden, T., Stover, S. & Hogg, R.S. HIV and Food Insecurity: A Syndemic Amid the COVID-19 Pandemic. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-02904-3
28. Kay, E.S., Musgrove, K. From HIV to Coronavirus: AIDS Service Organizations Adaptative Responses to COVID-19, Birmingham,
Alabama. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02879-1
29. Kowalska J, Skrzat-Klapaczyńska A, Bursa D, Balayan T, Begovac J, Chkhartishvili N et al. HIV care in times of the COVID-19 crisis —
Where are we now in Central and Eastern Europe? International Journal of Infectious Diseases. 2020; 96: 311-314.
https://doi.org/10.1016/j.ijid.2020.05.013
30. ONUSIDA. Enfermedad por Coronavirus (COVID-19) and HIV: Asuntos y Acciones Claves -OPS/OMS | Organización Panamericana de la Salud [Internet]. Paho.org. 2020 [cited 11 June 2020]. Available from: https://www.paho.org/es/documentos/enfermedad-por-coronavirus-covid19-and-hiv-asuntos-acciones-claves
31. Rights in the time of COVID-19 —Lessons from HIV for an effective, community-led response [Internet]. Unaids.org. 2020 [cited 15 June 2020]. Available from: https://www.unaids.org/en/resources/documents/2020/human-rights-andcovid-19
32. Wilkinson L, Grimsrud A. The time is now: expedited HIV differentiated service delivery during the COVID‐19 pandemic. Journal of the International AIDS Society. 2020;23(5). https://doi.org/10.1002/jia2.25503
33. Eaton L, Kalichman S. Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic. Journal of Behavioral Medicine. 2020;43(3):341-345. https://doi.org/10.1007/s10865-020-00157-y
34. Valdiserri, R.O., Holtgrave, D.R. Responding to Pandemics: What We’ve Learned from HIV/AIDS. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-02859-5
35. Hargreaves J, Davey C, Hargreaves J, Davey C, Auerbach J, Blanchard J et al. Three lessons for the COVID-19 response from pandemic HIV. The Lancet HIV. 2020;7(5): e309-e311. https://doi.org/10.1016/S2352-3018(20)30110-7
36. Edelman, E.J., Aoun-Barakat, L., Villanueva, M. et al. Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19
Response. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02908-z
37. Harkness, A., Behar-Zusman, V. & Safren, S.A. Understanding the Impact of COVID-19 on Latino Sexual Minority Men in a US HIV Hot
Spot. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02862-w
38. Algarin A, Varas-Rodríguez E, Valdivia C, Fennie K, Larkey L, Hu N et al. Symptoms, Stress, and HIVRelated Care Among Older People
Living with HIV During the COVID19 Pandemic, Miami, Florida. AIDS and Behavior. 2020;1-3. https://doi.org/10.1007/s10461-020-02869-3
39. Carrico, A.W., Horvath, K.J., Grov, C. et al. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS
Behav (2020). https://doi.org/10.1007/s10461-020-02854-w
40. Joseph Davey, D., Bekker, L., Coates, T.J. et al. Contracting HIV or Contracting SAR-CoV-2 (COVID19) in Pregnancy? Balancing the Risks and Benefits. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02861-x
41. Joska, J.A., Andersen, L., Rabie, S. et al. COVID-19: Increased Risk to the Mental Health and Safety of Women Living with HIV in South
Africa. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02897-z
42. Hightow-Weidman, L., Muessig, K., Claude, K. et al. Maximizing Digital Interventions for Youth in the Midst of Covid-19: Lessons from the Adolescent Trials Network for HIV Interventions. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02870-w
43. Rogers, B.G., Coats, C.S., Adams, E. et al. Development of Telemedicine Infrastructure at an LGBTQ+ Clinic to Support HIV Prevention and Care in Response to COVID-19, Providence, RI. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02895-1
44. Sanchez, T.H., Zlotorzynska, M., Rai, M. et al. Characterizing the Impact of COVID-19 on Men Who Have Sex with Men Across the United States in April, 2020. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02894-2
45. Strategic Considerations for Mitigating the Impact of COVID-19 on Key- Population-Focused HIV Programs [Internet]. Unaids.org. 2020 [cited 15 June 2020]. Available from: https://www.unaids.org/sites/default/files/media_asset/kp-strategicconsiderations-covid19_en.pdf
46. Operario, D., King, E.J. & Gamarel, K.E. Prioritizing Community Partners and Community HIV Workers in the COVID-19 Pandemic. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02896-0
47. Pinto, R.M., Park, S. COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02893-3
48. Shoptaw, S., Goodman-Meza, D. & Landovitz, R.J. Collective Call to Action for HIV/AIDS CommunityBased Collaborative Science in the Era of COVID-19. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02860-y
49. Ballester-Arnal, R., Gil-Llario, M.D. The Virus that Changed Spain: Impact of COVID-19 on People with HIV. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-02877-3
50. Marziali, M.E., Card, K.G., McLinden, T. et al. Physical Distancing in COVID-19 May Exacerbate Experiences of Social Isolation among People Living with HIV. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02872-8
51. Logie C. Lessons learned from HIV can inform our approach to COVID‐19 stigma. Journal of the International AIDS Society. 2020;23(5):1-3. https://doi.org/10.1002/jia2.25504
52. Krier, S., Bozich, C., Pompa, R. et al. Assessing HIV-Related Stigma in Healthcare Settings in the Era of the COVID-19 Pandemic, Pittsburgh, Pennsylvania. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02892-4
53. Logie, C.H., Turan, J.M. How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02856-8
54. Villanueva S. Infecciones y estigmas: lecciones de la pandemia del VIH para el mañana de la COVID-19 [Internet].
The Conversation. 2020 [cited 10 June 2020]. Available from: https://theconversation.com/infeccion es-y-estigmas-lecciones-de-lapandemia-del-vih-para-el-manana-dela-covid-19-135522
55. Relf MV. What's Old is New! Similarities Between SARS-CoV-2 and HIV. J Assoc Nurses AIDS Care. 2020;31(3):263‐265.
https://doi.org/10.1097/jnc.0000000000000174
2. Villamil-Gómez W, Sánchez Á, Gelis L, Silvera L, Barbosa J, Otero-Nader O et al. Fatal human coronavirus 229E (HCoV-229E) and RSV–Related pneumonia in an AIDS patient from Colombia. Travel Medicine and Infectious Disease. 2020; https://doi.org/10.1016/j.tmaid.2020.101573
3. Center for Disease Control [CDC]. What to know about HIV and COVID19. 2020 [cited 14 June 2020]. Available from:
https://www.cdc.gov/coronavirus/2019-ncov/need-extraprecautions/hiv.html
4. Yang R, Gui X, Gao S, et al. The reflection on an AIDS patient with asymptomatic COVID-19. Research Square [preprint]. 2020.
DOI: 10.21203/rs.3.rs-18738/v1
5. Favas, C. Guidance for the prevention of COVID-19 infections among high risk individuals in camps and camp like settings. London School of Hygiene & Tropical Medicine. 31 March 2020 [cited 11 June 2020]. Available from:
https://www.alnap.org/helplibrary/guidance-for-the-preventionof-covid-19-infection-among-highrisk-individuals-in-camps
6. Moni M, Liò P. Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies. BMC Bioinformatics.
2014;15(1):1-23. https://doi.org/10.1186/1471-2105-15-333
7. Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clinical Infectious Diseases [preprint]. 2020 [cited 7 June 2020]. Available from: https://pubmed.ncbi.nlm.nih.gov/3240 7467/
8. Härter, G., Spinner, C.D., Roider, J. et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection (2020). https://doi.org/10.1007/s15010-020-01438-z
9. Wu Q, Chen T, Zhang H. Recovery from COVID-19 in two patients with coexisted HIV infection. J Med Virol [preprint]. 2020 [cited 7 June 2020]. Recuperado de: https://doi.org/10.1002/jmv.26006
10. Blanco J, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J et al. COVID-19 in patients with HIV: clinical case series. The Lancet HIV. 2020;7(5): e314-e316. https://doi.org/10.1016/S2352-3018(20)30111-9
11. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey. Journal of Medical Virology [Internet]. 2020 [cited 8 June 2020];1-3. https://doi.org/10.1002/jmv.25955
12. Laurence J. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?. AIDS
Patient Care and STDs. 2020;34(6):247-248. https://doi.org/10.1089/apc.2020.29005.com
13. Zhao J, Liao X, Wang H, et al. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV [published online ahead of print, 2020 Apr 9]. Clin Infect Dis.2020; ciaa408. https://doi.org/10.1093/cid/ciaa408
14. Guo, Wei and Ming, Fangzhao and Dong, Yu and Zhang, Qian and Zhang, Xiaoxia and Mo, Pingzheng and Feng, Yong and Liang, Ke. A Survey for COVID-19 Among HIV/AIDS Patients in Two Districts of Wuhan, China. The Lancet [preprint]. Available at
http://dx.doi.org/10.2139/ssrn.3550029
15. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine. 2020;382(19):1787-1799. DOI: 10.1056/NEJMoa2001282
16. Copertino Jr. D, Lima B, Duarte R, Wilkin T, Gulick R, de Mulder Rougvie M et al. Antiretroviral Drug Activity and Potential for PreExposure Prophylaxis Against COVID-19 and HIV Infection. ChemRxiv [preprint]. 2020 [cited 8 June 2020]. Available from:
https://chemrxiv.org/articles/Antiretro viral_Drug_Activity_and_Potential_for_PreExposure_Prophylaxis_Against_COVID19_and_HIV_Infection/12250199/1?file=22537484
17. Mitjà O, Clotet B. Use of antiviral drugs to reduce COVID-19 transmission. The Lancet Global Health. 2020;8(5): e639-e640.
https://doi.org/10.1016/S2214-109X(20)30114-5
18. Lack of evidence to support use of darunavir-based treatments for SARSCoV-2 [Internet]. Janssen UK. 2020 [cited 15 June 2020]. Available from: https://www.janssen.com/uk/sars-cov2-treatment
19. Nyoni, T., Okumu, M. COVID-19- Compliant Strategies for Supporting Treatment Adherence Among People Living with HIV in Sub-Saharan Africa. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02888-0
20. Lodge W, Kuchukhidze S. COVID-19, HIV, and Migrant Workers: The Double Burden of the Two Viruses. AIDS Patient Care and STDs.
2020;34(6):249-250. DOI: https://doi.org/10.1089/apc.2020.0092
21. Shiau, S., Krause, K.D., Valera, P. et al. The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-02871-9
22. Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. The Lancet HIV. 2020;7(5): e308-e309.
https://doi.org/10.1016/S2352-3018(20)30105-3
23. Stanford, K.A., Friedman, E.E., Schmitt, J. et al. Routine Screening for HIV in an Urban Emergency Department During the COVID-19
Pandemic. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02899-x
24. Nosyk B, Armstrong W, del Rio C. Contact tracing for COVID-19: An opportunity to reduce health disparities and End the HIV/AIDS Epidemic in the US. Clinical Infectious Diseases [preprint]. 2020 [cited 7 June 2020]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197593/
25. Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. The Lancet HIV. 2020;7(5): e319-e320. https://doi.org/10.1016/S2352-3018(20)30109-0
26. Beima-Sofie, K., Ortblad, K.F., Swanson, F. et al. “Keep It Going if You Can”: HIV Service Provision for Priority Populations During the
COVID-19 Pandemic in Seattle, WA. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-0290
27. McLinden, T., Stover, S. & Hogg, R.S. HIV and Food Insecurity: A Syndemic Amid the COVID-19 Pandemic. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-02904-3
28. Kay, E.S., Musgrove, K. From HIV to Coronavirus: AIDS Service Organizations Adaptative Responses to COVID-19, Birmingham,
Alabama. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02879-1
29. Kowalska J, Skrzat-Klapaczyńska A, Bursa D, Balayan T, Begovac J, Chkhartishvili N et al. HIV care in times of the COVID-19 crisis —
Where are we now in Central and Eastern Europe? International Journal of Infectious Diseases. 2020; 96: 311-314.
https://doi.org/10.1016/j.ijid.2020.05.013
30. ONUSIDA. Enfermedad por Coronavirus (COVID-19) and HIV: Asuntos y Acciones Claves -OPS/OMS | Organización Panamericana de la Salud [Internet]. Paho.org. 2020 [cited 11 June 2020]. Available from: https://www.paho.org/es/documentos/enfermedad-por-coronavirus-covid19-and-hiv-asuntos-acciones-claves
31. Rights in the time of COVID-19 —Lessons from HIV for an effective, community-led response [Internet]. Unaids.org. 2020 [cited 15 June 2020]. Available from: https://www.unaids.org/en/resources/documents/2020/human-rights-andcovid-19
32. Wilkinson L, Grimsrud A. The time is now: expedited HIV differentiated service delivery during the COVID‐19 pandemic. Journal of the International AIDS Society. 2020;23(5). https://doi.org/10.1002/jia2.25503
33. Eaton L, Kalichman S. Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic. Journal of Behavioral Medicine. 2020;43(3):341-345. https://doi.org/10.1007/s10865-020-00157-y
34. Valdiserri, R.O., Holtgrave, D.R. Responding to Pandemics: What We’ve Learned from HIV/AIDS. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-02859-5
35. Hargreaves J, Davey C, Hargreaves J, Davey C, Auerbach J, Blanchard J et al. Three lessons for the COVID-19 response from pandemic HIV. The Lancet HIV. 2020;7(5): e309-e311. https://doi.org/10.1016/S2352-3018(20)30110-7
36. Edelman, E.J., Aoun-Barakat, L., Villanueva, M. et al. Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19
Response. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02908-z
37. Harkness, A., Behar-Zusman, V. & Safren, S.A. Understanding the Impact of COVID-19 on Latino Sexual Minority Men in a US HIV Hot
Spot. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02862-w
38. Algarin A, Varas-Rodríguez E, Valdivia C, Fennie K, Larkey L, Hu N et al. Symptoms, Stress, and HIVRelated Care Among Older People
Living with HIV During the COVID19 Pandemic, Miami, Florida. AIDS and Behavior. 2020;1-3. https://doi.org/10.1007/s10461-020-02869-3
39. Carrico, A.W., Horvath, K.J., Grov, C. et al. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS
Behav (2020). https://doi.org/10.1007/s10461-020-02854-w
40. Joseph Davey, D., Bekker, L., Coates, T.J. et al. Contracting HIV or Contracting SAR-CoV-2 (COVID19) in Pregnancy? Balancing the Risks and Benefits. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02861-x
41. Joska, J.A., Andersen, L., Rabie, S. et al. COVID-19: Increased Risk to the Mental Health and Safety of Women Living with HIV in South
Africa. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02897-z
42. Hightow-Weidman, L., Muessig, K., Claude, K. et al. Maximizing Digital Interventions for Youth in the Midst of Covid-19: Lessons from the Adolescent Trials Network for HIV Interventions. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02870-w
43. Rogers, B.G., Coats, C.S., Adams, E. et al. Development of Telemedicine Infrastructure at an LGBTQ+ Clinic to Support HIV Prevention and Care in Response to COVID-19, Providence, RI. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02895-1
44. Sanchez, T.H., Zlotorzynska, M., Rai, M. et al. Characterizing the Impact of COVID-19 on Men Who Have Sex with Men Across the United States in April, 2020. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02894-2
45. Strategic Considerations for Mitigating the Impact of COVID-19 on Key- Population-Focused HIV Programs [Internet]. Unaids.org. 2020 [cited 15 June 2020]. Available from: https://www.unaids.org/sites/default/files/media_asset/kp-strategicconsiderations-covid19_en.pdf
46. Operario, D., King, E.J. & Gamarel, K.E. Prioritizing Community Partners and Community HIV Workers in the COVID-19 Pandemic. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02896-0
47. Pinto, R.M., Park, S. COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02893-3
48. Shoptaw, S., Goodman-Meza, D. & Landovitz, R.J. Collective Call to Action for HIV/AIDS CommunityBased Collaborative Science in the Era of COVID-19. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02860-y
49. Ballester-Arnal, R., Gil-Llario, M.D. The Virus that Changed Spain: Impact of COVID-19 on People with HIV. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-02877-3
50. Marziali, M.E., Card, K.G., McLinden, T. et al. Physical Distancing in COVID-19 May Exacerbate Experiences of Social Isolation among People Living with HIV. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02872-8
51. Logie C. Lessons learned from HIV can inform our approach to COVID‐19 stigma. Journal of the International AIDS Society. 2020;23(5):1-3. https://doi.org/10.1002/jia2.25504
52. Krier, S., Bozich, C., Pompa, R. et al. Assessing HIV-Related Stigma in Healthcare Settings in the Era of the COVID-19 Pandemic, Pittsburgh, Pennsylvania. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02892-4
53. Logie, C.H., Turan, J.M. How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research. AIDS Behav (2020). https://doi.org/10.1007/s10461-020-02856-8
54. Villanueva S. Infecciones y estigmas: lecciones de la pandemia del VIH para el mañana de la COVID-19 [Internet].
The Conversation. 2020 [cited 10 June 2020]. Available from: https://theconversation.com/infeccion es-y-estigmas-lecciones-de-lapandemia-del-vih-para-el-manana-dela-covid-19-135522
55. Relf MV. What's Old is New! Similarities Between SARS-CoV-2 and HIV. J Assoc Nurses AIDS Care. 2020;31(3):263‐265.
https://doi.org/10.1097/jnc.0000000000000174
Autores/as
1.
Farias Aguilera A. VIH y COVID-19: Una revisión narrativa rápida. ceyes [Internet]. 31 de diciembre de 2021 [citado 16 de abril de 2026];6:103-18. Disponible en: https://revistas.userena.cl/index.php/cuidenf/article/view/1317
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.